UB Paderborn / Katalog / Suche / in CDI

A Spectrum of PCSK9 Alleles Contributes to Plasma Levels of Low-Density Lipoprotein Cholesterol

American journal of human genetics, 2006-03, Vol.78 (3), p.410-422

2006

Link zum Volltext

Verfügbarkeit prüfen

Multiple rare variants in NPC1L1 associated with reduced sterol absorption and plasma low-density lipoprotein levels

Proceedings of the National Academy of Sciences - PNAS, 2006-02, Vol.103 (6), p.1810-1815

2006

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness and tolerability of simvastatin plus fenofibrate for combined hyperlipidemia (the SAFARI trial)

The American journal of cardiology, 2005-02, Vol.95 (4), p.462-468

2005

Link zum Volltext

Verfügbarkeit prüfen

Impact of body mass and body composition on circulating levels of natriuretic peptides : Results from the dallas heart study

Circulation (New York, N.Y.), 2005-10, Vol.112 (14), p.2163-2168

2005

Link zum Volltext

Verfügbarkeit prüfen

Obesity, the metabolic syndrome, and cardiovascular disease

The American heart journal, 2001-12, Vol.142 (6), p.1108-1116

Vega, Gloria Lena

2001

Link zum Volltext

Verfügbarkeit prüfen

Interleukin-18, the metabolic syndrome, and subclinical atherosclerosis: results from the Dallas Heart Study

Arteriosclerosis, thrombosis, and vascular biology, 2007-09, Vol.27 (9), p.2043

2007

Link zum Volltext

Verfügbarkeit prüfen

African Americans and Caucasians have a similar prevalence of coronary calcium in the Dallas Heart Study

Journal of the American College of Cardiology, 2004-09, Vol.44 (5), p.1011-1017

2004

Link zum Volltext

Verfügbarkeit prüfen

No association between plasma levels of plant sterols and atherosclerosis in mice and men

Arteriosclerosis, thrombosis, and vascular biology, 2004-12, Vol.24 (12), p.2326

2004

Link zum Volltext

Verfügbarkeit prüfen

Effects of adding fenofibrate (200 mg/day) to simvastatin (10 mg/day) in patients with combined hyperlipidemia and metabolic syndrome

The American journal of cardiology, 2003-04, Vol.91 (8), p.956-960

2003

Link zum Volltext

Verfügbarkeit prüfen

Influence of Extended-Release Nicotinic Acid on Nonesterified Fatty Acid Flux in the Metabolic Syndrome With Atherogenic Dyslipidemia

The American journal of cardiology, 2005-06, Vol.95 (11), p.1309-1313

2005

Link zum Volltext

Verfügbarkeit prüfen

Normal triglyceride levels despite insulin resistance in African Americans: role of lipoprotein lipase

Metabolism, clinical and experimental, 2005-07, Vol.54 (7), p.902-909

2005

Link zum Volltext

Verfügbarkeit prüfen

Familial defective apolipoprotein B-100: a mutation of apolipoprotein B that causes hypercholesterolemia

Journal of lipid research, 1990-08, Vol.31 (8), p.1337-1349

1990

Link zum Volltext

Verfügbarkeit prüfen

Responsiveness of Plasma Lipids and Lipoproteins to Plant Stanol Esters

The American journal of cardiology, 2005-07, Vol.96 (1), p.23-28

2005

Link zum Volltext

Verfügbarkeit prüfen

Cardiovascular Outcomes for Obesity and Metabolic Syndrome

Obesity (Silver Spring, Md.), 2002-11, Vol.10 (s11), p.27S-32S

Vega, Gloria Lena

2002

Link zum Volltext

Verfügbarkeit prüfen

Hepatic lipase: new insights from genetic and metabolic studies

Current opinion in lipidology, 1999-06, Vol.10 (3), p.259-268

1999

Link zum Volltext

Verfügbarkeit prüfen

Management of atherogenic dyslipidemia of the metabolic syndrome: evolving rationale for combined drug therapy

Endocrinology and Metabolism Clinics of North America, 2004-09, Vol.33 (3), p.525-544

Vega, Gloria Lena

2004

Link zum Volltext

Verfügbarkeit prüfen

Hepatic lipase activity is lower in African American men than white American men: effects of 5' flanking polymorphism in the hepatic lipase gene (LIPC)

Journal of lipid research, 1998-01, Vol.39 (1), p.228-232

1998

Link zum Volltext

Verfügbarkeit prüfen

Correlation of statin-increased platelet APP ratios and reduced blood lipids in AD patients

Neurology, 2003-06, Vol.60 (12), p.2006

2003

Link zum Volltext

Verfügbarkeit prüfen

Free fatty acid metabolism during fenofibrate treatment of the metabolic syndrome

Clinical pharmacology and therapeutics, 2003-09, Vol.74 (3), p.236-244

2003

Link zum Volltext

Verfügbarkeit prüfen

Physiologic mechanisms for reduced apolipoprotein A-I concentrations associated with low levels of high density lipoprotein cholesterol in patients with normal plasma lipids

Journal of lipid research, 1992-10, Vol.33 (10), p.1527-1539

1992

Link zum Volltext

Verfügbarkeit prüfen

Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes: results of the assessment of diabetes control and evaluation of the efficacy of niaspan trial

Archives of internal medicine (1960), 2002-07, Vol.162 (14), p.1568

2002

Link zum Volltext

Verfügbarkeit prüfen

Hypoalphalipoproteinemia (low high density lipoprotein) as a risk factor for coronary heart disease

Current opinion in lipidology, 1996-08, Vol.7 (4), p.209-216

1996

Link zum Volltext

Verfügbarkeit prüfen

Hepatic lipase activity influences high density lipoprotein subclass distribution in normotriglyceridemic men: genetic and pharmacological evidence

Journal of lipid research, 1999-02, Vol.40 (2), p.229-234

1999

Link zum Volltext

Verfügbarkeit prüfen

Effect of Statins on Metabolism of Apo-B–Containing Lipoproteins in Hypertriglyceridemic Men

The American journal of cardiology, 1998-02, Vol.81 (4), p.36B-42B

1998

Link zum Volltext

Verfügbarkeit prüfen

Elevated hepatic lipase activity and low levels of high density lipoprotein in a normotriglyceridemic, nonobese Turkish population

Journal of lipid research, 1999-03, Vol.40 (3), p.432-438

1999

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

A Spectrum of PCSK9 Alleles Contributes to Plasma Levels of Low-Density Lipoprotein Cholesterol

Multiple rare variants in NPC1L1 associated with reduced sterol absorption and plasma low-density lipoprotein levels

Effectiveness and tolerability of simvastatin plus fenofibrate for combined hyperlipidemia (the SAFARI trial)

Impact of body mass and body composition on circulating levels of natriuretic peptides : Results from the dallas heart study

Obesity, the metabolic syndrome, and cardiovascular disease

Interleukin-18, the metabolic syndrome, and subclinical atherosclerosis: results from the Dallas Heart Study

African Americans and Caucasians have a similar prevalence of coronary calcium in the Dallas Heart Study

No association between plasma levels of plant sterols and atherosclerosis in mice and men

Effects of adding fenofibrate (200 mg/day) to simvastatin (10 mg/day) in patients with combined hyperlipidemia and metabolic syndrome

Influence of Extended-Release Nicotinic Acid on Nonesterified Fatty Acid Flux in the Metabolic Syndrome With Atherogenic Dyslipidemia

Normal triglyceride levels despite insulin resistance in African Americans: role of lipoprotein lipase

Familial defective apolipoprotein B-100: a mutation of apolipoprotein B that causes hypercholesterolemia

Responsiveness of Plasma Lipids and Lipoproteins to Plant Stanol Esters

Cardiovascular Outcomes for Obesity and Metabolic Syndrome

Hepatic lipase: new insights from genetic and metabolic studies

Management of atherogenic dyslipidemia of the metabolic syndrome: evolving rationale for combined drug therapy

Hepatic lipase activity is lower in African American men than white American men: effects of 5' flanking polymorphism in the hepatic lipase gene (LIPC)

Correlation of statin-increased platelet APP ratios and reduced blood lipids in AD patients

Free fatty acid metabolism during fenofibrate treatment of the metabolic syndrome

Physiologic mechanisms for reduced apolipoprotein A-I concentrations associated with low levels of high density lipoprotein cholesterol in patients with normal plasma lipids

Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes: results of the assessment of diabetes control and evaluation of the efficacy of niaspan trial

Hypoalphalipoproteinemia (low high density lipoprotein) as a risk factor for coronary heart disease

Hepatic lipase activity influences high density lipoprotein subclass distribution in normotriglyceridemic men: genetic and pharmacological evidence

Effect of Statins on Metabolism of Apo-B–Containing Lipoproteins in Hypertriglyceridemic Men

Elevated hepatic lipase activity and low levels of high density lipoprotein in a normotriglyceridemic, nonobese Turkish population

Suchergebnisse filtern